Dimensional Fund Advisors LP Ventyx Biosciences, Inc. Transaction History

Dimensional Fund Advisors LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$2.31 - $5.59 $813 - $1,967	-352 Reduced 2.93%	11,658 $26,000
Q1 2024 May 10, 2024	SELL	$1.9 - $10.13 $9,524 - $50,781	-5,013 Reduced 29.45%	12,010 $66,000
Q4 2023 Feb 07, 2024	SELL	$2.08 - $31.18 $178,620 - $2.68 Million	-85,875 Reduced 83.46%	17,023 $42,000
Q3 2023 Nov 09, 2023	SELL	$29.8 - $40.3 $1.82 Million - $2.46 Million	-61,149 Reduced 37.28%	102,898 $3.57 Million
Q2 2023 Aug 09, 2023	BUY	$28.53 - $39.55 $4.68 Million - $6.49 Million	164,047 New	164,047 $5.38 Million

125

52.9M

35.3K

83K

Ticker VTYX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,527,200
Market Cap $128M
Description
Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.